As of 30 Sep 2025, 1 institutional investors reported holding 1 shares of ALBIREO PHARMA INC - COMMON STOCK (ALBO).
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 1 | $744 | $744.00 | 1 | |
| 2025 Q2 | 1 | $744 | $744.00 | 1 | |
| 2025 Q1 | 1 | $744 | $744.00 | 1 | |
| 2024 Q4 | 1 | $744 | $744.00 | 1 | |
| 2024 Q3 | 1 | $744 | $744.00 | 1 | |
| 2024 Q2 | 1 | $744 | $744.00 | 1 | |
| 2024 Q1 | 1 | $744 | $744.00 | 1 | |
| 2023 Q4 | 1 | $744 | $744.00 | 1 | |
| 2023 Q3 | 1 | $744 | $744.00 | 1 | |
| 2023 Q2 | 1 | $756 | -$2,035,000 | $756.00 | 1 |
| 2023 Q1 | 46,081 | $2,035,799 | -$415,687,587 | $44.44 | 3 |
| 2022 Q4 | 18,610,820 | $401,651,185 | -$20,554,255 | $21.61 | 94 |
| 2022 Q3 | 19,143,878 | $370,387,747 | +$26,779,264 | $19.36 | 103 |
| 2022 Q2 | 17,754,471 | $352,558,617 | +$18,502,559 | $19.86 | 96 |
| 2022 Q1 | 16,604,290 | $495,386,841 | +$20,712,174 | $29.83 | 106 |
| 2021 Q4 | 15,564,742 | $362,483,495 | -$3,382,606 | $23.29 | 94 |
| 2021 Q3 | 15,287,193 | $476,975,740 | -$8,796,684 | $31.20 | 92 |
| 2021 Q2 | 15,522,619 | $546,133,262 | -$35,490,751 | $35.18 | 97 |
| 2021 Q1 | 16,735,026 | $589,776,641 | +$1,566,884 | $35.25 | 99 |
| 2020 Q4 | 16,671,414 | $625,315,261 | +$41,708,812 | $37.51 | 105 |
| 2020 Q3 | 16,254,769 | $542,366,618 | +$181,989,940 | $33.37 | 106 |
| 2020 Q2 | 10,264,658 | $271,875,564 | -$3,904,527 | $26.49 | 77 |
| 2020 Q1 | 10,438,997 | $170,709,481 | +$17,420,007 | $16.37 | 65 |
| 2019 Q4 | 9,002,263 | $228,838,800 | +$412,246 | $25.42 | 69 |
| 2019 Q3 | 9,052,163 | $181,039,060 | -$8,676,710 | $20.00 | 68 |
| 2019 Q2 | 9,259,119 | $298,421,543 | +$26,561,257 | $32.24 | 72 |
| 2019 Q1 | 8,470,619 | $272,758,817 | +$14,005,444 | $32.21 | 69 |
| 2018 Q4 | 8,037,472 | $194,513,403 | +$4,845,885 | $24.53 | 67 |
| 2018 Q3 | 7,731,860 | $254,843,089 | +$4,317,688 | $32.96 | 63 |
| 2018 Q2 | 7,595,688 | $269,653,825 | +$38,393,492 | $35.50 | 68 |
| 2018 Q1 | 6,541,586 | $213,070,205 | +$106,354,299 | $32.57 | 49 |
| 2017 Q4 | 3,193,501 | $81,755,000 | +$16,436,574 | $25.60 | 26 |
| 2017 Q3 | 2,597,832 | $54,423,000 | +$3,544,043 | $20.95 | 20 |
| 2017 Q2 | 2,429,234 | $50,043,000 | +$28,621,760 | $20.60 | 20 |
| 2017 Q1 | 1,033,960 | $24,813,000 | +$1,394,598 | $24.00 | 14 |
| 2016 Q4 | 978,234 | $17,342,000 | +$15,410,815 | $17.73 | 14 |
| 2016 Q3 | 108,667 | $47,000 | +$47,000 | $0.43 | 1 |